As expected, the two‐cutoff approach increased specificity; still, it did not decrease the sensitivity of plasma p‐tau217 and p‐tau217/Aβ42 ratio, thereby increasing the overall accuracy in classifying Aβ and tau PET statuses, as well as in diagnosing AD (Figure 6 and Figure S6). The gene discussed is MAPT; the disease is Alzheimer disease.